BioLife Solutions Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
BioLife Solutions (BLFS) PT Raised to $8 at Maxim Group
November 10, 2017 7:53 AM ESTMaxim Group raised its price target on BioLife Solutions (NASDAQ: BLFS) to $8.00 (from $7.00) while maintaining a Buy rating.
Analyst Jason McCarthy notes the company reported 3Q17 with $3.0M in revenue, up 16% sequentially and 39% YoY. Growth continues to be driven by both Cryostor (freezing media)... More
